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MORN5 (MORN repeat containing 5) is encoded by a locus positioned on chromosome
17 in the chicken genome. The MORNmotif is found in multiple copies in several proteins
including junctophilins or phosphatidylinositol phosphate kinase family and the MORN
proteins themselves are found across the animal and plant kingdoms. MORN5 protein
has a characteristic punctate pattern in the cytoplasm in immunofluorescence imaging.
Previously, MORN5 was found among differentially expressed genes in a microarray
profiling experiment of the chicken embryo head. Here, we provided in situ hybridization
to analyse, in detail, the MORN5 expression in chick craniofacial structures. The
expression of MORN5 was first observed at stage HH17-18 (E2.5). MORN5 expression
gradually appeared on either side of the primitive oral cavity, within the maxillary region.
At stage HH20 (E3), prominent expression was localized in the mandibular prominences
lateral to the midline. From stage HH20 up to HH29 (E6), there was strong expression in
restricted regions of the maxillary and mandibular prominences. The frontonasal mass (in
the midline of the face) expressed MORN5, starting at HH27 (E5). The expression was
concentrated in the corners or globular processes, which will ultimately fuse with the
cranial edges of the maxillary prominences. MORN5 expression was maintained in the
fusion zone up to stage HH29. In sectionsMORN5 expression was localized preferentially
in the mesenchyme. Previously, we examined signals that regulateMORN5 expression in
the face based on a previous microarray study. Here, we validated the array results with in
situ hybridization and QPCR. MORN5 was downregulated 24 h after Noggin and/or RA
treatment. We also determined that BMP pathway genes are downstream of MORN5
following siRNA knockdown. Based on these results, we conclude that MORN5 is both
regulated by and required for BMP signaling. The restricted expression ofMORN5 in the
lip fusion zone shown here supports the human genetic data in which MORN5 variants
were associated with increased risk of non-syndromic cleft lip with or without cleft palate.
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INTRODUCTION
The vertebrate face is formed very early in development from
the paired maxillary and mandibular prominences and the
single frontonasal mass surrounding the oral cavity. These facial
prominences arise during early embryogenesis from interactions
between neural crest derived mesenchyme and head ectoderm.
The frontonasal mass grows out, contacts and fuses together
with the maxillary prominences to form the upper jaw. The
midline facial skeleton consisting of the nasal septum, prenasal
cartilage and premaxilla are all derived from the frontonasal
mass (Richman and Lee, 2003). Craniofacial development is
complex process coordinated by a network of transcription
factors and signaling molecules (Murray and Schutte, 2004; Chai
and Maxson, 2006; Jiang et al., 2006; Brunskill et al., 2014;
Kurosaka, 2015; Marcucio et al., 2015; Nimmagadda et al., 2015).
Disruption of this tightly controlled cascade can result in clefts
where the facial prominences fail to meet and fuse (Leslie and
Marazita, 2013).
Cleft lip and/or cleft palate are the most common craniofacial
birth defects in humans (Setó-Salvia and Stanier, 2014; Watkins
et al., 2014). The majority of clefts appear as isolated or
non-syndromic clefts, because they occur in isolation from
other developmental abnormalities. The causes of clefting are
thought to be multifactorial, including an interaction between
genes and the environmental factors (Schutte and Murray,
1999; Dixon et al., 2011; Leslie and Marazita, 2013; Setó-
Salvia and Stanier, 2014; Watkins et al., 2014). Identification
of genes contributing to clefts formation is important not
only for our understanding of facial development, but also
for improved prevention and treatment of affected individuals.
The chicken embryo is a valuable experimental model to study
the signals that control lip fusion. The avian primary palate
closely resembles the primary palate in mammals (Abramyan
et al., 2015). Moreover, the face can be accessed directly in the
living embryo through a window in the shell. The disruption
of FGF (Szabo-Rogers et al., 2008), BMP (Ashique et al., 2002),
SHH (Hu et al., 2015), and WNT signaling (Geetha-Loganathan
et al., 2014) causes a cleft lip in chickens that resembles that of
humans.
Previously, a microarray study was performed to profile gene
expression in individual chicken facial prominences in stage
18 embryos (Buchtová et al., 2010). From the list of genes
that were significantly more highly expressed in the maxillary
prominence, we selected MORN5 (also known as C9orf113,
C9orf18 or FLJ46909) for further studies because it was described
as a cleft susceptibility gene (Letra et al., 2010). Microarray
analysis revealed 24 times higher expression of MORN5 in the
maxillary prominence compared to expression in the frontonasal
mass at stage 18, while mandibular prominence showed 10 times
higher expression than the frontonasal mass (Buchtová et al.,
2010).
Members of theMORN family were named for the presence of
multipleMORNmotifs (MembraneOccupation and Recognition
Nexus). There are five paralogous genes in the MORN
family (MORN1-5). Limited functional information is available
for a subset of MORN genes. MORN1 has been identified
in the parasite Toxoplasma gondii and other Apicomplexan
protists where it plays role during cell division (Ferguson
et al., 2008; Lorestani et al., 2010). Human MORN2 was
found to facilitate phagocytosis-mediated restriction of some
bacteria in macrophages (Abnave et al., 2014). Expression
of MORN3 was detected in mouse testis, where it regulates
spermatogenesis (Zhang et al., 2015). Finally, MORN4 promotes
axonal degeneration in mouse sensory axons (Bhattacharya et al.,
2012).
In chicken, theMORN5 gene is located on the forward strand
of chromosome 17. On the reverse strand, NDUFA8 and LHX6
genes are nearby to the MORN5 gene. The size of the MORN5
gene is 13.5 kb and there are 6 exons (only 5 exons are coding)
with four splice variants. The MORN5 gene encodes a protein
of 172 amino acids, which contains a histone H3 K4-specific
methyltransferase SET7/9 N-terminal domain (SSF82185) and
three MORNmotifs (Figure 1).
As the gene expression pattern or possible function ofMORN5
during development had not been investigated in any animal
model, we aim to analyzed chicken MORN5 expression in
embryos and its integration into signaling pathways.
MATERIALS AND METHODS
Embryonic Material
Fertilized chicken eggs (ISA brown) were obtained from the farm
Integra (Žabcˇice, Czech Republic). Eggs were incubated in a
humidified forced air incubator at 37.8◦C. Embryos were staged
and morphological characteristic were described according to
Hamburger andHamilton (1951). All procedures were conducted
following a protocol approved by the Laboratory Animal Science
Committee of the Institute of Animal Physiology and Genetics
(Libeˇchov, Czech Republic).
Section In situ Hybridization (ISH)
Chicken MORN5 was obtained as chicken EST clone CHEST ID
543 F09 (Biovalley, France), where the probe sequence was cloned
into pBluescript II KS+ vector. The entire region containing
the probe sequence flanked by T3 and T7 RNA polymerase
sites was amplified using M13 primers (forward primer: 5′-
GTA AAA CGA CGG CCA G-3′, reverse primer: 5′-CAG GAA
ACA GCT ATG AC-3′). Then, the amplicon was isolated via gel
purification (QIAquick Gell Extraction Kit, Qiagen, Germany)
and this linearized DNA fragment was used in RNA polymerase
reactions. DIG labeled antisense riboprobe was synthesized with
T3 RNA polymerase (antisense) or with T7 polymerase (sense
controls).
Embryos were fixed in 4% paraformaldehyde (PFA), processed
through ethanol and xylene into paraffin, and sectioned for ISH.
Hybridization was performed with RNA probe at 60◦C overnight
as described previously (Holland et al., 1996). Anti-digoxigenin
sheep antibody conjugated with alkaline phosphatase (1:2000,
Roche, USA) was applied overnight at 4◦C. Visualization was
achieved by incubation with substrates for alkaline phosphatase
(BM Purple AP, Roche, Germany) for several days. Slides were
then counterstained with eosin. ISH was carried out on at least
three embryos for each stage.
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FIGURE 1 | Gene characteristics of chickenMORN5 and domain analysis. MORN5 gene is located on chromosome 17 of the chicken genome and its length is
13.5 kb. The gene is composed of 6 exons where the last one is non-coding. The open reading frame codes for a protein 172 amino acids in length. The gene
contains SSF82185 domain and three MORN motifs.
Embryo Manipulations
Embryos were treated with beads soaked in All-trans retinoic
acid (RA), Noggin protein, Tris or Dimethyl Sulfoxide (DMSO)
as described (Lee et al., 2001). Since DMSO was the solvent for
RA, we used DMSO bead as a control for RA treatment and
Tris as a control for Noggin treatment. AG1-X2 beads (Bio-
Rad Laboratories, Hercules, Canada) of 100µm in diameter
were soaked in RA (cat. No. R2625 Sigma) at a concentration
of 1mg/ml for 1 h as previously described (Lee et al., 2001;
Nimmagadda et al., 2015). Noggin proteins were soaked into
Affigel blue beads (Bio-Rad Laboratories, Hercules, Canada) of
200µm diameter for a minimum of 1 h at a concentration of
1mg/ml (cat. No. 1967-NG, R&D Systems, Minneapolis, USA).
Control beads were soaked with DMSO or Tris. Two beads
were implanted into the maxillary region on the right side of
chicken embryo at stage HH15. For ISH andQPCR, samples were
collected 24 h post-bead implantation, embedded into paraffin
and processed for ISH.
Immunofluorescence on Slides
Embryos were collected at stage HH24 for MORN5 protein
detection. Chicken duodenum was used as a control according
to the manufacturer’s instruction. Samples were fixed in 4%
PFA and processed into paraffin. Following deparaffinization and
rehydration, antigen retrieval was carried out using citrate buffer
for 1min at 97◦C. Polyclonal antibody to MORN5 (1:50, cat. No.
NBP1-91230, Novus Biologicals, USA) was applied overnight at
4◦C. The secondary anti-rabbit antibody (1:200, Alexa Fluor 594,
cat. No. A-21207) was applied for 30min at RT. Sections were
washed in PBS and coverslipped with Prolong Gold anti-fade
reagent containing DAPI (cat. No. P36935, Invitrogen, USA).
Quantitative RT-PCR
Gene expression of MORN5 was analyzed on tissues isolated
from normal chicken prominences at stage 15, 18, 20, and
26. Moreover, Noggin or RA treated maxillary prominences
were dissected 24 h following bead implantation at stage 15.
Prominences were pooled from at least 15 embryos to produce
one sample and 4 biological replicates were analyzed. Total RNA
was extracted using the Mini RNeasy Kit (Qiagen, Germany)
according to the manufacturer’s instructions. The total RNA
concentration and purity of each sample were assessed by
spectrophotometry using a NanoDrop1000 (Thermo Scientific,
Waltham, USA). First-strand cDNA was synthesized using
the SuperScript Vilo cDNA synthesis Kit (cat. No. 11754050,
Thermo Fisher, USA). The qPCR was performed in 10µl
final reaction volumes containing the one-step master mix
(no AmpErase UNG, cat. No. 4324018, Applied Biosystems,
Carlsbad, USA) mixed with MORN5 (TaqMan Assays, Assay
ID: AJKAKYV, context sequence: TTCCTGAGAAATGCAGAC
GATGAGG, FAM-MGB, Applied Biosystems, Austin, USA) on
LightCycler R© 96 (Roche,Manheim, Germany) with preheating at
95◦C/10min, followed by 40 cycles of 95◦C/15 s and 60◦C/1min.
Gene expression levels were calculated using11CTmethodwith
normalization against the HPRT1 level (TaqMan Assays, Assay
ID: Gg033338900_m1, context sequence: TTGAATCATATC
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TGTGTGATCAGTG, FAM-MGB, Applied Biosystems, Austin,
USA), which was used as the housekeeping gene. Means of
3 technical replicates were generated for each of 3 biological
replicates and these values were used for statistical analysis.
All procedures were repeated in at least three independent
experiments.
Transfection with MORN5 Plasmids in Cell
Cultures
The expression vector containing C-terminally FLAG-tagged
human MORN5 was obtained from OriGene (Rockville, MD).
HEK293T cells were obtained from ATCC (Manassas, VA)
and propagated in DMEM media (Sigma-Aldrich, St. Louis,
MO) with 10% fetal bovine serum, 1% Pen/Strep and 1% l-
glutamin (Invitrogen, Carlsbad, CA). Cells were transfected
using FUGENE6 reagent according to manufacturer’s protocol
(Promega).
HEK293T cells grown on glass coverslips were fixed with
4% PFA (RT/15min), permeabilized with 0.1%Triton-X100 in
PBS (RT/5min), and incubated with the following antibodies
at 4◦C overnight: MORN5 (1:100, cat. No. NBP1-91230, Novus
Biologicals), FLAG (1:200, cat. No. F1804, Sigma-Aldrich). The
secondary antibody AlexaFluor 488 (1:500; cat. No. A21206, Life
Technologies) or AlexaFluor 594 (1:500; cat. No. A21203, Life
Technologies) were used. Coverslips were mounted into DAPI-
containing Mowiol. Images were taken on an LSM700 laser
scanning microscope with acquisition done using ZEN Black
2012 software (Zeiss, Jenna, Germany).
siRNA Targeting gMORN5 in Chicken
Embryos
Silencer Select custom designed siRNA (gMORN5, cat. No.
4399666, Ambion, Austin, USA) was mixed with FUGENE
6 (Roche, Mannheim, Germany), and then was injected into
the maxillary prominence of chicken embryos. Negative siRNA
(Silencer select negative control No.1 siRNA, cat. No. 4390843,
Ambion, Austin, USA) was used as a control. The first injection
of siRNA was performed at stage HH20 and the second one after
24 h about stage HH24. One day later after the second injection,
embryos had reached stage HH28 and maxillary prominences
were dissected for RNA isolation. Tissues were dissected from 5
embryos to form one sample and three biological samples were
used for treated embryos (MORN5 siRNA) as well as for control
(Silencer select negative control No.1 siRNA) embryos.
PCR Arrays
Total RNA was extracted from siRNA treated maxillary
prominences using the Mini RNeasy Kit (Qiagen, Germany)
according to the manufacturer’s instructions. First-strand cDNA
was synthesized using the SuperScript Vilo cDNA synthesis Kit
(cat. No. 11754050, Thermo Fisher, USA). Downregulation of
MORN5 expression after injection was first confirmed using
qPCR before further processing for PCR Array analysis.
Custom made Chick-bone plates (KRD, Czech Republic)
were used for analysis of BMP pathway genes. The PCR arrays
were performed in 12µl final reaction volumes containing
SYBR Premix Ex Taq II (cat. No RR0821A, Takara, Japan) on
LightCycler R© 96 (Roche, Manheim, Germany) with preheating
at 95◦C/30min, followed by 45 cycles of 95◦C/5 s, 60◦C/20 s and
72◦C/15 s. Data were statistically evaluated by 11CT method
with normalization against HPRT1 levels. In each PCR array
plate, there were three technical replicates for 24 genes, and 2
technical replicates for an additional 13 genes.
Statistical Analysis
All results were expressed asmeans± standard deviations (SD) of
three samples for each treatment and were compared by unpaired
two-tailed Student’s t-test for qPCR and PCR Array. Differences
were considered to be significant at p < 0.05.
RESULTS
Spatiotemporal Gene Expression Pattern
of MORN5 in Facial Prominences
First, we analyzed spatiotemporal expression pattern of MORN5
in individual prominences of chicken face. Facial prominences
begin to form during early embryonic development. In
situ hybridization showed no expression in chicken face at
Hamburger-Hamilton (HH) stage 15 (50–55 h of incubation,
Figures 2A–C) which is shortly after neural crest cells have
entered the face. Later at stage HH17 (52-64 h of incubation,
Figures 2D–F), MORN5 expression appeared in the caudal part
FIGURE 2 | Gene expression of MORN5 in early chicken face. (A–C)
Frontal sections of chicken face at stage HH15. (D–F) Frontal sections of
chicken face at stage 17. (D,E) In the ventral part of maxillary and mandibular
prominences, there was no expression. (F) MORN5 expression gradually
appeared dorsally in caudal part of maxillary region. (G–I) Frontal sections of
chicken face at stage HH18. MORN5 expression was strong in maxilla and
also in central part of each mandibular prominence (G). MdP, mandibular
prominence; MxP, maxillary prominence. Scale bars = 100µm.
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of the presumptive maxillary mesenchyme close to the maxillo-
mandibular cleft. At stage HH18, the bulge of the maxillary
prominence contained high levels of MORN5 transcripts (65–
69 h of incubation, Figures 2G–I). Expression was also detected
in the dorsal (oral side) part of the mandibular prominences
close to the maxillo-mandibular cleft (Figures 2G,H). At
stage HH20 (70–72 h of incubation), there continued to be
restricted expression in caudal and medial domains within the
maxillary prominences (Figures 3A–C). In the mandibular
prominences, there was expression in the cranial mesenchyme
on either side of the midline groove (Figures 3A–O) with the
exceptions of mesenchymal condensations of Meckel’s cartilage
(Figures 3B,C). At stage HH24 (4 days of incubation), maxillary
prominence enlarged and strongMORN5 expression was present
throughout the mesenchyme (Figures 3E–G). Mandibular
expression was similar to stage HH20 (Figures 2E–G). Thus,
FIGURE 3 | Gene expression of MORN5 in later stages of chicken embryo. (A–C) ISH analysis in frontal sections of chicken head at stage HH20. There was
strong expression in the maxillary prominence. The expression appeared in the cranial part in each mandibular prominence and it continued in dorsal direction. (B) No
expression was observed in mesenchymal condensations and close to the fusion region of mandibular prominences. (E–G) MORN5 expression in frontal section of
chicken head at stage HH24. MORN5 expression was strong in the mesenchyme of maxillary prominences. MORN5 expression was localized in the dorsal part of
mandibular prominence, but not in mesenchymal condensation and close to the midline. (I–K) Frontal sections of chicken head at stage HH27 showed prominent
expression in the maxillary prominence. There was weak expression in the globular process. Prominent expression was observed in rostral part of maxillary
prominence and also in the mandibular prominence with the exception of midline. (M–O) Frontal sections of chicken head at stage 29 where beak is evident. MORN5
expression was localized in rostral part of maxilla and in fusion region. In the mandibular prominence, there was strong expression but not in the midline. (D,H,L,P) ISH
analysis using sense probe. FNM, frontonasal mass; GP, globular process; mc, mesenchymal condensation; MdP, mandibular prominence; MxP, maxillary
prominence. Scale bars = 100µm.
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MORN5 is expressed in a restricted pattern in neural crest-
derived mesenchyme but not in epithelium. Sense probe did not
show signal in the maxillary prominence (Figures 3D,H,L,P).
MORN5 Expression in the Lip Fusion Zone
at Later Stages
The next critical phase of facial morphogenesis is the fusion
of the lip. Between stage HH27–29, the cranial-medial edges of
the maxillary prominences meet the lateral corners of medial
nasal prominences (globular processes) and fuse (Abramyan
et al., 2015). At stage HH27 (5 days of incubation), MORN5
expression was observed for the first time in the corners of the
frontonasal mass (globular processes, Figures 3I,J). Expression
in the maxillary prominences was high in the rostral-medial
corner just where fusion with the globular processes will take
place. There continued to be expression in the mandibular
prominences similar to stage 24 (Figures 3I–K). At stage HH29
(6 days of incubation), MORN5 expression was located in the
region of lip fusion (Figures 3M,N) as well as in the mandible.
This is the first stage where expression of MORN5 in Meckel’s
cartilage was detected (Figure 3M). Further confirmation of
the restricted expression in the lip fusion zone is shown in
other embryos cut in the frontal (Figures 4A–C) or transverse
plane at stage HH29 (Figures 4A–F). Note that mesenchymal
bridging has taken place by stage HH29, unifying the domains
of expression ofMORN5 in the globular processes and maxillary
prominences (Figures 4B,C).
To quantify the relative levels of expression between the
stages of development, we performed QPCR for evaluation of
MORN5 expression level in each prominence at four different
stages (HH15, 18, 20, 26). Since stage HH15, we did not observe
any expression of MORN5 by ISH, this level of expression
was chosen as the reference value for 11Ct analysis for
individual prominences. In the maxillary prominence, MORN5
expression gradually increased during development with the
peak level seen at stage HH20 (Figure 5A). In the mandibular
prominence, we observed significantly increased expression
at stage HH20 and 26 compared to stage HH15 embryos
(Figure 5B). In the frontonasal mass, MORN5 expression is
very low except of the globular processes we were surprised
to see a statistically significant increase in expression of
stage HH20 embryos (Figure 5C). In the section of in situ
experiments, we could not detect MORN5 at stage HH20
(data not shown) therefore sensitivity of QPCR is greater
than in situ hybridization. By stage HH27, there is expression
of MORN5 in the in situ experiments; however, QPCR data
did not pick up a significant expression level in stage HH26
embryos (Figure 5C). Some of the variability may be due to
the dissection process and whether the globular process was
included in all the samples. We did not compare expression
levels between the facial prominences due to the experimental
design.
MORN5 Protein Expression in the Face
To correlate MORN5 protein distribution with MORN5
gene expression, we performed immunofluorescence staining.
MORN5 protein was localized in developing chicken face at stage
FIGURE 4 | MORN5 expression in the fusion region at stage 29. (A–C)
Frontal sections of chicken head showed strong expression in the maxilla and
in the area where edges of the maxillary prominences grow together with
medial nasal prominence. (D–F) Horizontal sections of chicken head. (E)
Region of fusion had prominent MORN5 expression. (F) More caudal section
(other sample). Scale bars = 100µm.
HH24, with the most prominent expression in individual cells
in the maxillary and mandibular prominences (Figures 6A–H).
Thus, only a subset of cells expressingMORN5RNA expresses the
protein. In positive control (adult chicken intestine), there was
expected signal in Goblet cells, in the apical parts of enterocytes
and in fibroblasts of the lamina propria (Figures 6I–L).
The specificity of the MORN5 antibody was also confirmed
in HEK293T cells transfected with a MORN5-FLAG plasmid
(Figures 7A–C). The staining of MORN5 and FLAG antibodies
overlapped (Figures 7A–C). Similar to tissue section data,
exogenous MORN5 protein was found in the cytoplasm in a
punctate pattern (Figures 7D,E).
Downregulation of MORN5 after Noggin a
Retinoic Acid Treatment
Our study uncovered high levels of MORN5 expression in
normal chicken embryos, however a previous study from
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FIGURE 5 | QPCR analysis of MORN5 expression during face
development. (A) In the maxillary prominence, there was most prominent
expression at stage HH20. All analyzed stages showed statistically significant
overexpression in comparison to stage HH15. (B) In the mandibular
prominence, we observed significant expression at stage HH20 and 26. (C)
Very low MORN5 expression was detected in the frontonasal mass at stage
HH15 and 18, but at stage HH20 was MORN5 expression significantly
increased. FNM, frontonasal mass; MdP, mandibular prominence; MxP,
maxillary prominence. t-test; ***p < 0.001, **0.001 < p < 0.01, *p < 0.05.
our group discovered that MORN5 was downregulated in an
experimental paradigm involving beads implanted into the
chicken face (Nimmagadda et al., 2015). Beads soaked in the
bone morphogenetic protein antagonist, Noggin and retinoic
acid (RA) synergistically induced transformation of the maxillary
prominence into the frontonasal mass (Lee et al., 2001). The
tissues from embryos induced to form this duplicated beak
were profiled using microarrays. A significant downregulation
of MORN5 expression was observed in all the treatment groups
compared to controls treated with DMSO-Tris beads (-3.77-
fold Noggin-DMSO treatment, -3.68-fold Noggin-RA, -2-fold
after RA-Tris treatment) (Nimmagadda et al., 2015). We wanted
to follow up this findings since it appeared that the RA and
BMP pathways were upstream regulators of MORN5 and that
possibly MORN5 was one of a set of genes mediating the beak
duplication phenotype. First, we validated the array results using
QPCR on maxillary tissues collected from treated and control
embryos. We found a significant downregulation of MORN5
after Nogin-RA and Noggin-DMSO treatment compared to Tris-
DMSO controls (Figure 8A). Next, we asked whether there were
any spatial differences in MORN5 expression induced by the
bead implants using in situ hybridization. Control embryos
implanted with beads soaked in DMSO-Tris showed strong
expression in the maxillary region and maxillo-mandibular cleft
(Figure 8B). In contrast, no expression was observed in the
maxillary prominence of Noggin-RA or Noggin-DMSO treated
embryos. Interestingly, there was residual expression ofMORN5
observed in embryos treated with RA-Tris located just under the
epithelium of maxilla-mandibular cleft (Figure 8B).
Downregulation of MORN5 by siRNA
Altered Gene Expression of BMP and TGFβ
Pathways Members
We had discovered that BMP activity was required for MORN5
expression but next wanted to investigate the genes that might be
downstream ofMORN5. As the first group of potential targets, we
studied genes that are known to be in the BMP pathway.MORN5
expression in the maxillary prominence was downregulated to
75% of control levels following transfectionwith siRNA (2 rounds
of transfection: at stage 20 and 24; Figure 9A). We used a PCR
array that included 34 genes specific for the BMP pathway with
HPRT1 acting as the reference control gene (Table S1).
Eight genes showed a statistically significant increase in their
expression caused by partial MORN5 silencing (Figure 9B).
These included ENG (Endoglin), Gdf2 (Growth differentiation
factor 2, also BMP9), PLAU (plasminogen activator, urokinase),
FST (Follistatin), Runx1 (Runt-related transcription factor 1),
ID1 (Inhibitor of DNA binding 1), TGFβR2 (Transforming
growth factor beta receptor 2) and TGFβ3 (Figure 9B). The
most striking increase was seen with GDF2 (increased 3.5-fold).
Statistically significant downregulation was observed only in the
case of BMP5 (Figure 9B). It is interesting thatMORN5 normally
represses ID1, a transcription factor that positively regulates BMP
signaling. Although levels of ID1 were increased, which should
imply higher BMP signaling, there is also decreased expression of
the BMP5 ligand. It is likely that cytoplasmic MORN5 indirectly
regulates the expression of these genes and that further work
is needed to determine the intermediate mediators of BMP and
TGFβ signaling affected byMORN5.
DISCUSSION
Here, we found spatially and temporally restricted expression
of MORN5 in the face area during embryonic development
suggesting its role in patterning of the maxillary prominences.
Moreover, there was expression in the globular processes of
frontonasal mass just before their fusion with the maxillary
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FIGURE 6 | MORN5 protein detected by immunofluorescent labeling. (B,D) MORN5 protein was localized in the maxillary prominences at stage HH24. (F,H) In
the mandibular prominence, there is very low signal in the mesenchyme. MORN5 expression showed dispersed pattern of distribution. (A,C,E,G) DAPI staining. (I–L)
Chicken intestine was used as a positive control with strong positivity in Goblet cells (gc), in the apical parts of enterocytes and also spotted expression in fibroblasts
(fb). MdP, mandibular prominence; MxP, maxillary prominence.
prominences. Previously, a human genetics study found that
MORN5 was associated with non-syndromic cleft lip with or
without cleft palate (NSCLP) (Letra et al., 2010). We are the
first to document expression of MORN5 in the relevant parts
of the face undergoing lip fusion. In addition, there is strong
expression on the medial sides of the maxillary prominences, the
sites where palatal shelves will arise. While the chicken has a
naturally cleft palate, it is interesting that MORN5 is expressed
in the intermediate stages of palatal shelf formation. Based on
previous microarray studies carried out on the chicken face,
MORN5 came up twice, once as a maxillary enriched gene
(Buchtová et al., 2010) and second as a differentially expressed
gene following Noggin and RA bead implants (Nimmagadda
et al., 2015). Taken together, the human genetic and chicken data
suggest that MORN5 is an important maxillary patterning and
possibly lip fusion gene. Thus, it would be worthwhile targeting
MORN5 using mouse models and to include this gene in human
NSLCP studies.
Complex signaling interactions coordinate the outgrowth of
facial prominences to form the adult face. Some of factors have
been previously identified by whole genome expression screens
or by candidate gene mapping. The BMP signaling pathway
regulates many cellular processes of craniofacial development
and it is necessary for mesenchymal outgrowth of facial
prominences. The expression of BMPs in chicken face was
found at the time prior and during lip fusion (Ashique
et al., 2002). BMP4 transcripts were previously detected in the
epithelium of the globular processes of frontonasal mass and
MORN5 expression underlays the same area however entirely
in the mesenchyme. Also in the maxillary and mandibular
prominences, epithelial BMP4 expression was described in
parallel areas to mesenchymal MORN5. Furthermore, BMP2
and BMP7 were previously detected in the mesenchyme of
both facial prominences. Maxillary and mandibular prominences
express also several downstream target of BMP signaling.
MSX1 is strongly expressed in the maxillary prominence but
in slightly different pattern than MORN5 in the mandible
(Shigetani et al., 2000; Fuchs et al., 2010). There are additional
transcription factors that appear to overlap with MORN5
specifically in the frontonasal mass globular processes and
maxillary prominences, TBX22, DLX5, and MSX2 (Higashihori
et al., 2010). These transcription factors may regulate expression
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FIGURE 7 | Cytosolic spotted pattern of MORN5 expression in
HEK293T cells. (A–C) HEK293T cells were transfected with FLAG-tagged
MORN5-expressing vector and immunostained using both FLAG and MORN5
antibodies. Cells expressing transgenic MORN5 were also MORN5-positive
pointing to the specificity of the antibody. (D,E) In addition, a cytosolic spotted
pattern of MORN5 expression was present in non-transfected cells. Scale bars
= 100µm.
of MORN5. Interestingly, in the microarray study on beak
duplicated embryos, TBX22 was upregulated following Noggin-
RA treatment and TBX22 acts as a transcriptional repressor.
It will be necessary to analyze whether MORN5 is a target of
TBX22 which is a known clefting gene in humans (Kantaputra
et al., 2011). It is interesting to note that the gene LHX6 which
is located 3′ to MORN5 on the opposite strand was reported to
be highly expressed in the chicken face (Washbourne and Cox,
2006). Expression of LHX6 begins in the maxillo-mandibular
cleft at stage 18 similar toMORN5 (Washbourne and Cox, 2006).
There is also striking similarity of expression of LHX6 in the
globular processes and medial maxillary prominences at stage
27. This suggests that the two genes may share some common
enhancers that drive expression in particular regions of the
face.
MORN5 knockdown revealed indirect roles for this gene
in controlling the expression of BMP and TGFB signaling
pathways. Since we have shown MORN5 is a cytoplasmic
protein it is unlikely that it is directly involved in regulating
gene transcription. Further biochemical studies are needed to
determine the exact function of MORN5 in the cell. Nevertheless,
the RNA changes we observed suggest a subset of genes are
dependent on MORN5 for their expression. We did not study
the TGFB pathway in our bead implantation studies; therefore,
the PCR array data extended our original findings on MORN5
FIGURE 8 | QPCR analysis and ISH of MORN5 expression after bead
implantation. (A) QPCR analysis showed 1.68 times downregulation after
RA-Tris, 3.03 after Noggin-DMSO and 2.59 after Noggin-RA treatment in
comparison to control DMSO-Tris. (B) Control embryos implanted with beads
soaked in DMSO-Tris had strong expression in maxillary region and
maxilla-mandibular cleft. In RA-Tris treated embryos was very weak MORN5
expression. After Noggin-DMSO treatment, expression was rapidly decreased.
No expression of MORN5 was observed after Noggin-RA treatment. Nog,
Noggin; RA, Retinoic acid; TD, Tris-DMSO. Scale bars = 100µm. t-test;
*p < 0.05.
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FIGURE 9 | BMP pathway gene expression after MORN5 downregulation. (A) Downregulation of MORN5 expression after siRNA treatment. (B) MORN5
downregulation caused significant increase in GDF2, ENG, TGFBR2, TGFB3, PLAU, FST, RUNX1, and ID1 expression. Statistically significant downregulation was
observed only in case of BMP5. t-test; **0.001 < p < 0.01, *p < 0.05.
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function. The most highly upregulated gene, GDF2, is known to
associate with Endoglin (Castonguay et al., 2011) a glycoprotein
located on cell surfaces that serves as a co-receptor for members
of the Transforming growth factor-β superfamily (Cheifetz et al.,
1992). This suggests that activity of TGFβ family is normally
repressed by MORN5. Other changes such as the increase
in the antagonist FST (Follistatin) may indicate that MORN5
operates in another way to regulate TGF signaling. MORN5 may
normally repress this antagonist, which binds members of the
TGFβ superfamily with a particular focus on activin (Lambert-
Messerlian et al., 2007). We have shown that FST does not induce
skeletal changes in the palate as compared to Noggin (Celá et al.,
2016) therefore FST regulation by MORN5 may serve different
functions outside of facial morphogenesis. Several other genes
known to be in the TGFB pathway and essential for mouse palate
development were upregulated including RUNX1 (Yamashiro
et al., 2002), TGFβ3 (Cui et al., 1998) and ID1 (Rice et al., 2005).
In summary, we discovered that MORN5 is involved in TGFB
signaling at all levels. In conclusion, BMP signaling is required for
MORN5 expression and reduction ofMORN5 derepresses several
genes in the BMP and TGFβ signaling pathways. Furthermore,
MORN5 has two potential roles in facial patterning, to specify
maxillary identity and to regulate lip fusion that warrant further
study in animal models.
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